LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

LEVELS OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL DO NOT NEGATIVELY IMPACT THE ABILITY OF THE PCSK9 INHIBITOR, EVOLOCUMAB, TO PROMOTE REGRESSION OF CORONARY ATHEROSCLEROSIS

Photo by nci from unsplash

Levels of non-HDL-C reflect the total circulating pool of atherogenic lipid factors and have been associated with ongoing plaque progression on statin treatment. It is unknown whether these levels modulate… Click to show full abstract

Levels of non-HDL-C reflect the total circulating pool of atherogenic lipid factors and have been associated with ongoing plaque progression on statin treatment. It is unknown whether these levels modulate the degree of regression observed with addition of a proprotein convertase subtilisin kexin

Keywords: regression; high density; density lipoprotein; lipoprotein cholesterol; levels non; non high

Journal Title: Journal of the American College of Cardiology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.